This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the HeartRhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. EDT, in Rhythm Theater #2.
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. Early recurrence of atrial tachyarrhythmia (ERAT) is commonly seen following catheter ablation of AF, with reported incidences of up to 61% in the first three months.
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
In a study published in HeartRhythm, researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, analyzed real-world clinical data to measure the impact of evidence-based best-practices on patient outcomes for the most common AF procedure: radiofrequency (RF)-based ablation.
EGF mapping allows physicians to detect EGF sources and is designed to individualize ablation strategies based on underlying pathophysiologic mechanisms to potentially improve outcomes. AFib is the most common heartrhythm disorder, affecting more than 30 million patients worldwide.
Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablateheart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.
Atrial fibrillation (AFib) is a common heartrhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options.
It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University HeartRhythm Management Centre. COMING AHEAD: www.adncoe.com
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University HeartRhythm Management Centre. COMING AHEAD: www.adncoe.com
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. At this year’s HeartRhythm Society (HRS) conference in Boston in May, innovation, again, was the focus. Pulsed field ablation (PFA) is all the rage in electrophysiology.
Background Evaluating outcomes of concurrent Cox-Maze procedures in elderly patients undergoing high-risk cardiac surgery. Cox-Maze IV AF ablation. Heartrhythm was assessed from Holter reports or 12-lead ECG. Sinus rhythm at annual and latest follow-up was 84.9% They were subdivided into two groups: 1.
will have AF, an irregular and potentially dangerous heartrhythm. ii The DEFINE AFib clinical study enrolled 973 patients using an app-based enrollment feature and characterized the impact of AF burden on patient outcomes and quality of life. By 2030, approximately 12.2 million people in the U.S. 2024, May 15).
Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heartrhythm that can lead to poor blood flow. It occurs when the heart's upper chambers (atria) beat out of sync with the lower chambers (ventricles). www.adncoe.com
Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heartrhythm that can lead to poor blood flow. It occurs when the heart's upper chambers (atria) beat out of sync with the lower chambers (ventricles). www.adncoe.com
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
Expert Consensus Statement and Remote Patient Monitoring Guidelines What does the HeartRhythm Society’s new Expert Consensus Statement say? We at Vector are thrilled to continue our contribution to the team effort to support clinics in their journey to improve outcomes for cardiac device patients.
Atrial fibrillation often shortened to AFib is an irregular and often rapid heartrhythm that can lead to serious health complications. Here are some of the most common: Medication – Your doctor may prescribe medications like blood thinners to reduce the risk of blood clots and control heart rate and rhythm.
Atrial fibrillation, or AFib, is the most common type of heartrhythm disorder (arrhythmia), affecting over 6 million Americans, and the number is expected to double by 2030. Catheter ablation is a minimally invasive procedure that disables portions of heart tissue that cause irregular heartrhythms. “In
RPM solutions are improving healthcare outcomes and helping patients lead healthier lives. Since it was announced as a Class 1A recommendation in 2015 by the HeartRhythm Society, cardiac remote patient monitoring has become the standard of care for cardiac device patients. What is Cardiac Remote Patient Monitoring Software ?
During its Annual Conference, HRS 2024, the HeartRhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF).
1,2 People living with AFib face an increased risk of stroke, heart failure and death, and many rely on cardiac ablation to treat the condition effectively. of veins during ablation procedures with far fewer energy applications than on-market competitive PFA systems. 3 Following approval, initial cases were completed by Prof.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Our mission to combat complex heartrhythm diseases relies on optimizing interoperability.
The VARIPULSE Platform is comprised of the VARIPULSE Catheter, a fully integrated variable-loop multielectrode catheter; the TRUPULSE Generator, a pulsed field ablation (PFA) generator; and the CARTO 3 System VARIPULSE Software, which provides full integration with the world's leading 3D cardiac mapping system.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). iii] The study reported a low fluoroscopy time of 7.8
The “ MANIFEST-17K ” international study is the first to show important safety outcomes in a large patient population, including no significant risk of esophageal damage, with PFA. PFA is the latest ablation modality approved by the Food and Drug Administration that can be used to restore a regular heartbeat. and Harry B. and Harry B.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content